JP2024518791A5 - - Google Patents
Info
- Publication number
- JP2024518791A5 JP2024518791A5 JP2023570177A JP2023570177A JP2024518791A5 JP 2024518791 A5 JP2024518791 A5 JP 2024518791A5 JP 2023570177 A JP2023570177 A JP 2023570177A JP 2023570177 A JP2023570177 A JP 2023570177A JP 2024518791 A5 JP2024518791 A5 JP 2024518791A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- alkyl
- formula
- carboxamide
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188498P | 2021-05-14 | 2021-05-14 | |
| US63/188,498 | 2021-05-14 | ||
| US202263334717P | 2022-04-26 | 2022-04-26 | |
| US63/334,717 | 2022-04-26 | ||
| PCT/US2022/029118 WO2022241175A1 (en) | 2021-05-14 | 2022-05-13 | Substituted heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518791A JP2024518791A (ja) | 2024-05-02 |
| JP2024518791A5 true JP2024518791A5 (https=) | 2025-05-21 |
Family
ID=81928066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023570177A Pending JP2024518791A (ja) | 2021-05-14 | 2022-05-13 | 置換ヘテロ環化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240270723A1 (https=) |
| EP (1) | EP4337656A1 (https=) |
| JP (1) | JP2024518791A (https=) |
| KR (1) | KR20240007242A (https=) |
| WO (1) | WO2022241175A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12492184B2 (en) | 2020-12-22 | 2025-12-09 | InventisBio Co., Ltd. | Heteroaryl compounds, preparation methods and uses thereof |
| CA3208361A1 (en) | 2021-02-19 | 2022-08-25 | Anjali Pandey | Tyk2 inhibitors and uses thereof |
| EP4294806A1 (en) | 2021-02-19 | 2023-12-27 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| AU2022222470A1 (en) | 2021-02-19 | 2023-09-21 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| KR20240008337A (ko) * | 2021-05-14 | 2024-01-18 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 헤테로시클릭 화합물 |
| US20240317718A1 (en) * | 2021-05-14 | 2024-09-26 | Bristol-Myers Squibb Company | Substituted heterocyclic compounds |
| US11884650B2 (en) * | 2021-05-14 | 2024-01-30 | Bristol-Myers Squibb Company | Substituted heterocyclic compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3495358T (lt) * | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| AU2019373203B2 (en) * | 2018-10-30 | 2024-10-24 | Bristol-Myers Squibb Company | Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha |
| JP7740849B2 (ja) * | 2021-05-04 | 2025-09-17 | シャンハイ ゼイ バイオテクノロジー カンパニー リミテッド | 含窒素複素環ピリジン化合物 |
| KR20240008337A (ko) * | 2021-05-14 | 2024-01-18 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 헤테로시클릭 화합물 |
| US20240317718A1 (en) * | 2021-05-14 | 2024-09-26 | Bristol-Myers Squibb Company | Substituted heterocyclic compounds |
| PE20250262A1 (es) * | 2021-05-14 | 2025-01-29 | Bristol Myers Squibb Co | Compuestos heterociclicos sustituidos |
| US11884650B2 (en) * | 2021-05-14 | 2024-01-30 | Bristol-Myers Squibb Company | Substituted heterocyclic compounds |
-
2022
- 2022-05-13 JP JP2023570177A patent/JP2024518791A/ja active Pending
- 2022-05-13 WO PCT/US2022/029118 patent/WO2022241175A1/en not_active Ceased
- 2022-05-13 KR KR1020237042722A patent/KR20240007242A/ko active Pending
- 2022-05-13 EP EP22727682.1A patent/EP4337656A1/en active Pending
- 2022-05-13 US US18/560,496 patent/US20240270723A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518791A5 (https=) | ||
| JP2024518555A5 (https=) | ||
| JP2024518792A5 (https=) | ||
| TW202334116A (zh) | 一種取代的苯丙酸衍生物及其用途 | |
| JP2006502143A5 (https=) | ||
| EA032609B1 (ru) | Соединения аминопиримидинила в качестве ингибиторов jak | |
| JP2023035972A (ja) | ２－［（４－｛６－［（４－シアノ－２－フルオロベンジル）オキシ］ピリジン－２－イル｝ピペリジン－１－イル）メチル］－１－［（２ｓ）－オキセタン－２－イルメチル］－１ｈ－ベンズイミダゾール－６－カルボン酸、１，３－ジヒドロキシ－２－（ヒドロキシメチル）プロパン－２－アミン塩の固体形態 | |
| JP2023531709A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| TW201716370A (zh) | 作為化療劑的β－取代的β－氨基酸和類似物及其應用 | |
| WO2023001296A1 (zh) | 作为parp7抑制剂的哒嗪酮类化合物 | |
| US20240376048A1 (en) | Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases | |
| US20210047314A1 (en) | Sultam Compound And Application Method Thereof | |
| TW201609734A (zh) | 用於治療寄生蟲疾病之化合物及組合物 | |
| JP2024509760A5 (https=) | ||
| JP2025527291A5 (https=) | ||
| US11498904B2 (en) | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | |
| CN110139857A (zh) | 作为吲哚胺2,3-双加氧酶抑制剂的亚砜亚胺、磺酰亚胺酰胺、磺酰二亚胺和二酰亚胺磺酰胺化合物 | |
| US10556875B2 (en) | Bis-diazeniumdiolate compounds as anti-cancer agents | |
| JP2022546208A (ja) | 置換尿素ジヒドロオロト酸デヒドロゲナーゼ阻害剤 | |
| WO2024168004A1 (en) | Biaryl amide-containing agonists of orexin receptor type 2 | |
| JP2020525417A5 (https=) | ||
| CN1191528A (zh) | 具有褪黑激素受体结合亲合力的苯并环烯化合物,其生产方法和用途 | |
| WO2022266427A1 (en) | 4-(aryl-methyl-amino)-quinazoline derivatives and uses thereof | |
| JP6292568B2 (ja) | ウレア誘導体化合物、これを含有する放射性医薬 |